BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

707 related articles for article (PubMed ID: 30527792)

  • 1. Intravenous Thrombolysis After Idarucizumab Application in Acute Stroke Patients-A Potentially Increased Sensitivity of Thrombi to Lysis?
    Pretnar Oblak J; Sabovic M; Frol S
    J Stroke Cerebrovasc Dis; 2019 Mar; 28(3):768-773. PubMed ID: 30527792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous Thrombolysis in Acute Ischemic Stroke After Idarucizumab Reversal of Dabigatran Effect: Analysis of the Cases From Taiwan.
    Fang CW; Tsai YT; Chou PC; Chen HM; Lu CM; Tsao CR; Chen CL; Sun MC; Shih YS; Hsieh CY; Chen LA; Chen PL; Yeh JT; Li YH
    J Stroke Cerebrovasc Dis; 2019 Mar; 28(3):815-820. PubMed ID: 30573284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous Thrombolysis in Patients with Acute Ischemic Stroke after a Reversal of Dabigatran Anticoagulation with Idarucizumab: A Real-World Clinical Experience.
    Šaňák D; Jakubíček S; Černík D; Herzig R; Kunáš Z; Mikulík R; Ostrý S; Reif M; Rohan V; Tomek A; Veverka T
    J Stroke Cerebrovasc Dis; 2018 Sep; 27(9):2479-2483. PubMed ID: 29807757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute Stroke Despite Dabigatran Anticoagulation Treated with Idarucizumab and Intravenous Tissue Plasminogen Activator.
    Bissig D; Manjunath R; Traylor BR; Richman DP; Ng KL
    J Stroke Cerebrovasc Dis; 2017 Jun; 26(6):e102-e104. PubMed ID: 28416406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic Thrombolysis in Acute Ischemic Stroke after Dabigatran Etexilate Reversal with Idarucizumab-A Case Report.
    Tireli D; He J; Nordling MM; Wienecke T
    J Stroke Cerebrovasc Dis; 2017 Jul; 26(7):e123-e125. PubMed ID: 28479184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proposed approach to thrombolysis in dabigatran-treated patients presenting with ischemic stroke.
    Kate M; Szkotak A; Witt A; Shuaib A; Butcher K
    J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1351-5. PubMed ID: 24406026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversing dabigatran effect with idarucizumab to enable intravenous thrombolysis in patients with acute ischaemic stroke - a single centre experience.
    Włodarczyk E; Sawczyńska K; Wrona P; Słowik A
    Neurol Neurochir Pol; 2023; 57(6):465-476. PubMed ID: 37955597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Idarucizumab in Dabigatran-Treated Patients with Acute Ischemic Stroke Receiving Alteplase: A Systematic Review of the Available Evidence.
    Pikija S; Sztriha LK; Sebastian Mutzenbach J; Golaszewski SM; Sellner J
    CNS Drugs; 2017 Sep; 31(9):747-757. PubMed ID: 28808918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous Thrombolysis With Recombinant Tissue-Type Plasminogen Activator in a Stroke Patient Receiving Dabigatran Anticoagulant After Antagonization With Idarucizumab.
    Berrouschot J; Stoll A; Hogh T; Eschenfelder CC
    Stroke; 2016 Jul; 47(7):1936-8. PubMed ID: 27301937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antagonizing dabigatran by idarucizumab in cases of ischemic stroke or intracranial hemorrhage in Germany - A national case collection.
    Kermer P; Eschenfelder CC; Diener HC; Grond M; Abdalla Y; Althaus K; Berrouschot J; Cangür H; Daffertshofer M; Edelbusch S; Gröschel K; Haase CG; Harloff A; Held V; Kauert A; Kraft P; Lenz A; Müllges W; Obermann M; Partowi S; Purrucker J; Ringleb PA; Röther J; Rossi R; Schäfer N; Schneider A; Schuppner R; Seitz RJ; Szabo K; Wruck R
    Int J Stroke; 2017 Jun; 12(4):383-391. PubMed ID: 28494694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful intravenous thrombolysis for ischemic stroke after reversal of dabigatran anticoagulation with idarucizumab: a case report.
    Agosti S; Casalino L; Rocci E; Zaccone G; Rota E
    J Med Case Rep; 2017 Aug; 11(1):224. PubMed ID: 28806993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dabigatran Reversal Before Intravenous Tenecteplase in Acute Ischemic Stroke.
    Beharry J; Waters MJ; Drew R; Fink JN; Wilson D; Campbell BCV; Parsons MW; Kleinig TJ; Wu TY
    Stroke; 2020 May; 51(5):1616-1619. PubMed ID: 32208845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous Fibrinolysis in Ischemic Stroke of Large Vessel after Reversing Effect of Dabigatran with Idarucizumab.
    Alvarez Bravo G; Orts Castro E; Carvalho Monteiro G; López Zuazo I
    J Stroke Cerebrovasc Dis; 2017 Sep; 26(9):e192-e193. PubMed ID: 28663010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of intravenous thrombolysis on stroke associated with atrial fibrillation.
    Padjen V; Jovanovic D; Berisavac I; Ercegovac M; Stefanovic Budimkic M; Stanarcevic P; Beslac Bumbasirevic L
    J Stroke Cerebrovasc Dis; 2014 Sep; 23(8):2199-2205. PubMed ID: 25018112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dabigatran Reversal With Idarucizumab Preceding Thrombolysis in an Octogenarian Patient with Chronic Kidney Disease and Acute Stroke: A Case Report.
    Laxamana LC; Co COC; Yu JRT; Mojica CV; Iboleon-Dy MAM; Domingo AMC; Ilano KCS; Macrohon-Valdez MCZ
    Clin Ther; 2020 Sep; 42(9):1840-1845. PubMed ID: 32778345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombolysis for acute ischemic stroke: do patients treated out of hours have a worse outcome?
    Fang K; Churilov L; Weir L; Dong Q; Davis S; Yan B
    J Stroke Cerebrovasc Dis; 2014 Mar; 23(3):427-32. PubMed ID: 23635920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Idarucizumab Reversal of Dabigatran in Patients with Acute Ischemic Stroke and Intracranial Hemorrhage: Comparison with Non-idarucizumab-Treated Patients.
    Frol S; Sernec LP; Hudnik LK; Šabovič M; Oblak JP
    CNS Drugs; 2021 Feb; 35(2):233-242. PubMed ID: 33548038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generalized Safety and Efficacy of Simplified Intravenous Thrombolysis Treatment (SMART) Criteria in Acute Ischemic Stroke: The MULTI SMART Study.
    Sørensen SB; Barazangi N; Chen C; Wong C; Grosvenor D; Rose J; Bedenk A; Morrow M; McDermott D; Hove JD; Tong DC
    J Stroke Cerebrovasc Dis; 2016 May; 25(5):1110-1118. PubMed ID: 26897101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclusion of ischemic stroke patients from intravenous tissue plasminogen activator treatment for mild symptoms should not be based on low National Institutes of Health Stroke Scale Scores.
    Wendt M; Tütüncü S; Fiebach JB; Scheitz JF; Audebert HJ; Nolte CH
    J Stroke Cerebrovasc Dis; 2013 May; 22(4):550-3. PubMed ID: 23433783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute reversal of dabigatran with Idarucizumab for intravenous thrombolysis as acute stroke treatment.
    Meyer D; Chu F; Derry K; Hailey L
    J Clin Neurosci; 2019 Jan; 59():355-357. PubMed ID: 30309801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.